Multidrug-resistant organism colonization in critically ill cirrhotic patients: Marker or mediator of mortality? [0.03%]
多重耐药菌定植在重症肝病患者中是死亡的标志还是介导因素？
Shi-San Bao,Yan Lu
Shi-San Bao
Bacterial infections are a key precipitant of acute decompensation and acute-on-chronic liver failure in cirrhotic patients. The rising prevalence of multidrug-resistant organisms complicates intensive care unit management, making colonizat...
Uncovering silent carriers: Hematological insights and viral burden in incidentally detected hepatitis B virus infection [0.03%]
沉默携带者的研究：偶然发现的慢性HBV感染患者的血液学特征和病毒学特征分析
Manisha M Ratnaparkhi,Chanda R Vyawahare,Parag J Ratnakar et al.
Manisha M Ratnaparkhi et al.
Background: Hepatitis B Virus (HBV) remains a global public health challenge, affecting over 296 million people, many of whom are asymptomatic. Incidentally diagnosed carriers provide a critical window for early intervent...
Evaluation methods of hepatic steatosis: From conventional techniques to emerging biomarkers [0.03%]
肝脂肪变性的评估方法：从传统技术到新兴生物标志物
Kengo Moriyama
Kengo Moriyama
Accurate assessment of hepatic steatosis is essential for diagnosing, staging, and monitoring metabolic dysfunction-associated steatotic liver disease. This review comprehensively overviews conventional and emerging hepatic steatosis evalua...
Current management strategies for sarcopenia and frailty in cirrhosis: Missing link in transplant candidacy [0.03%]
肝硬化的 sarcopenia 和衰弱的当前管理策略：移植候选人中的缺失环节
Manjeet Kumar Goyal,Rishi Chowdhary,Chirag Vohra et al.
Manjeet Kumar Goyal et al.
Sarcopenia and frailty are pervasive, interrelated syndromes in cirrhosis that worsen morbidity, quality of life, transplantation waitlist outcomes, and post-transplant survival. This review synthesized contemporary evidence on definitions,...
Ji-Wei Qin,Jian-Cheng Wu,Hao Zheng et al.
Ji-Wei Qin et al.
Background: This report describes the development of schizophrenia in a 63-year-old female patient approximately six months after undergoing liver transplantation. The patient exhibited no previous indications of psychiat...
Impact of multidisciplinary steatotic liver disease management on bariatric surgery referral and clinical outcomes: A retrospective cohort study [0.03%]
多学科脂肪肝病管理对代谢手术转诊和临床结局影响的回顾性队列研究
Andrew W Schwartz,Emily Y Park,Ysabel C Ilagan-Ying et al.
Andrew W Schwartz et al.
Background: Lifestyle modifications aimed at weight loss are key to improving metabolic dysfunction-associated steatotic liver disease (MASLD); however, achieving substantial and sustained weight loss through non-surgical...
Harnessing artificial intelligence in gastroenterology and hepatology: Current applications and future perspectives [0.03%]
人工智能在胃肠病学和肝病学中的应用：现状与未来展望
Panagiotis Boutos,Konstantina-Eleni Karakasi,Georgios Katsanos et al.
Panagiotis Boutos et al.
Artificial intelligence (AI) has made remarkable strides, becoming an essential tool in modern medicine. As AI continues to evolve, it is crucial to redefine its scope, classifications, and subtypes to better align with its clinical applica...
Evaluation of the impact of an interdisciplinary team scheduling model on psychological outcomes in patients with decompensated cirrhosis [0.03%]
评估跨学科团队预约模式对失代偿期肝硬化患者心理结果的影响评价
Wei-Ying Xu,Ye-Qin Li,Xiu-Ping Wei et al.
Wei-Ying Xu et al.
Background: Patients with decompensated cirrhosis frequently experience severe psychological distress, anxiety, and depression, yet psychological support is often fragmented in conventional care. ...
Application of modified Charlson comorbidity index for predicting outcomes following adult living donor liver transplantation [0.03%]
改良Charlson合并症指数在预测成人活体肝移植术后预后中的应用
Gowtham Rajan,Amal Francis Sam,Akila Rajakumar et al.
Gowtham Rajan et al.
Background: The model for end-stage liver disease (MELD) score helps assess the severity of liver disease and can predict survival after liver transplant. The Charlson comorbidity index (CCI) is frequently employed to for...
Noninvasive liver fibrosis assessment in metabolic dysfunction-associated steatotic liver disease [0.03%]
代谢异常相关性肝脂肪变性肝病的非侵入式肝纤维化评估
Tarsila C R Ribeiro,Vitor de Paula Boechat Soares,Julia Campos Fabri et al.
Tarsila C R Ribeiro et al.
Metabolic-dysfunction-associated steatotic liver disease (MASLD) is a leading cause of chronic liver disease worldwide, with global prevalence estimated at about 32%. The main predictor of clinical outcome is liver fibrosis severity, making...